EJC Supplements
Volume 5, Issue 2 , Pages 5-12 , July 2007

Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients

  • Giampaolo Bucaneve

      Affiliations

    • Istituto di Medicina Interna e Scienze Oncologiche, Azienda Ospedaliera di Perugia, Policlinico Monteluce, 06100 Perugia, Italy
    • Corresponding Author InformationCorresponding author: Tel.: +39 075 5724160; fax: +39 075 5783444.
    • ,
  • Elio Castagnola

      Affiliations

    • Unità di Malattie Infettive, Dipartimento di Ematologia e Oncologia, Ospedale “G.Gaslini”, Genova, Italy
    • ,
  • Claudio Viscoli

      Affiliations

    • Clinica Malattie Infettive, Università di Genova, Azienda Ospedale-Università “San Martino”, Genova, Italy
    • ,
  • Leonard Leibovici

      Affiliations

    • Department of Medicine “E. Rabin” Medical Center, Beilinson Campus Petah-Tiqva, Israel
    • ,
  • Francesco Menichetti

      Affiliations

    • Unità di Malattie Infettive, Ospedale Cisanello, Pisa, Italy

Received 14 May 2007 ,Revised 6 June 2007 ,Accepted 11 June 2007.

  • Image Result

    Fluoroquinolone prophylaxis: publications identified and exclusions (1980–2005).

    Fluoroquinolone prophylaxis: publications identified and exclusions (1980–2005).

☆ The ECIL-1 is a common initiative of the following groups or organisations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (EORTC-IDG), European Leukaemia Net (ELN) (EU Grant No. LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).

PII: S1359-6349(07)00004-3

doi: 10.1016/j.ejcsup.2007.06.002

EJC Supplements
Volume 5, Issue 2 , Pages 5-12 , July 2007

Article Tools

* Image Usage & Resolution